"At Acuity Pharmaceuticals we faced many challenges back in 2003. Five years later, we can view our scientific and financial successes with the benefit of hindsight to seek the contributing factors to that success. BioAdvance was one of the first companies we presented our company to. We received quick feedback and then were involved in a thorough diligence process which gave us more input and encouragement. At that early juncture, BioAdvance decided to invest, yet it was far more than money that made the difference. The BioAdvance team provided contacts and an effective sounding board for our development during those formative years."
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
Today’s Top Regional Life Sciences Stories from Business Wire
| SAFE-BioPharma® Standard to be Highlighted at Molecular TriCon |
| FORT LEE, N.J.--(BUSINESS WIRE)--SAFE-BioPharma interoperable digital identities in assuring secure cloud computing will be featured at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference |
| Incyte to Present at the Leerink Swann 2012 Global Healthcare Conference |
| WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16, 2012 at 2:30 p.m. (ET) in New York. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 90 days. Investors interested in listening to the live webcast should log on before the start time in order t |
| Teleflex to Focus on Innovative Products at the Society of Critical Care Medicine’s 41st Critical Care Congress |
| LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) will showcase a number of anesthesia, respiratory therapy and vascular access products at the Society of Critical Care Medicine’s 41st Critical Care Congress February 4-8, in Houston, Texas. Teleflex will highlight: The Teleflex ISIS® HVT™, the first convertible endotracheal tube, features an integrated suction port and separate suction line allowing for subglottic secretion suctioning on demand. Now clinicians can be free from th |
| OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology |
| YARDLEY, Pa.--(BUSINESS WIRE)--OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration (FDA) in December, 2011. The FDA has completed its review and has notified OptiNose that the studies under this IND may proceed. The Company will initiate Phase III trials in adults with acute migraine with or without aura utilizing its novel intranasal technology. “This filing signals an important milestone in our quest to deliver improved relief to p |
| Regulatory Harmonization Institute and Korea Health Industry Development Institute Partner to Launch 2012 Columbus Project |
| ELMWOOD PARK, N.J.--(BUSINESS WIRE)--The Regulatory Harmonization Institute, Inc. (RHI) an international, not-for-profit association dedicated to global harmonization of drug and medical device regulatory requirements, and the Korea Health Industry Development Institute (KHIDI), the Korean government organization, announced today to partner in support of the 2012 Columbus Project, a Korean government program to boost globalization of Korea’s healthcare industry. KHIDI has enrolled 42 Korean manu |
| Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results |
| WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2011. $ in millions, except EPS amounts FourthQuarter2011 FourthQuarter2010 Year EndedDec. 31,2011 Year EndedDec. 31,2010 Sales $12,294 $12,094 $48,047 $45,987 GAAP EPS 0.49 (0.17) 2.02 0.28 Non-GAAP EPS that excludes items listed below1 0.97 0.88 3.77 3.42 GAAP Net Income (Lo |
| Acsis, Inc. Releases the latest ProducTrak™ Solutions |
| MARLTON, N.J.--(BUSINESS WIRE)--Acsis, Inc. announces the latest version of its ProducTrak solution suite, designed to provide complete product visibility across the supply network. |
| The Ben Franklin Technology Partners $50,000 BIG IDEA Business Plan Contest is Still Running! |
| STATE COLLEGE, Pa.--(BUSINESS WIRE)--Ben Franklin Technology Partners of Central & Northern Pennsylvania will award a grand prize of $50,000 to one tech-based startup or entrepreneur. |
| AtlantiCare Special Care Center Receives Premier Cares Award, $100,000 for Innovative, Successful Management of Chronic Conditions |
| CHARLOTTE, N.C.--(BUSINESS WIRE)--AtlantiCare Special Care Center receives Premier Cares Award, $100,000 for innovative, successful management of chronic conditions |
| Almac Announce Launch of Next Generation Sequencing (NGS) Data Analysis Services |
| CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac’s Diagnostics business unit today announced launch of its advanced Next Generation Sequencing (NGS) data Analysis services. These latest enhancements to Almac’s service portfolio include a comprehensive range of NGS solutions from professional study design to sample processing and expert data analysis for DNA and RNA samples. Uniquely, the services are highly customizable and are available on a standalone basis or in combination with Almac’s es |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.